Alison Hannah
2020
In 2020, Alison Hannah earned a total compensation of $1.7M as Senior Vice President and Chief Medical Officer at CytomX Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $197,063 |
|---|---|
| Option Awards | $1,023,425 |
| Salary | $412,500 |
| Other | $45,000 |
| Total | $1,677,988 |
Hannah received $1M in option awards, accounting for 61% of the total pay in 2020.
Hannah also received $197.1K in non-equity incentive plan, $412.5K in salary and $45K in other compensation.
Rankings
In 2020, Alison Hannah's compensation ranked 6,338th out of 13,090 executives tracked by ExecPay. In other words, Hannah earned more than 51.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,338 out of 13,090 | 52nd |
Division Manufacturing | 2,611 out of 5,621 | 54th |
Major group Chemicals And Allied Products | 1,053 out of 2,254 | 53rd |
Industry group Drugs | 909 out of 1,954 | 54th |
Industry Pharmaceutical Preparations | 679 out of 1,459 | 54th |
Source: SEC filing on April 27, 2022.
Hannah's colleagues
We found four more compensation records of executives who worked with Alison Hannah at CytomX Therapeutics in 2020.